Neuropsychiatric sequalae of COVID-19
Brief description of study
The purpose of this study is to explore possible neurological complications resulting from prior COVID-19 infection. Neurological symptoms, including ‘brain fog’, depression, and/or anxiety can be disabling. This study aims to determine the prevalence and severity of these symptoms. Unfortunately, little is known about these neuropsychiatric symptoms, particularly in patients with preexisting diseases, such as HIV. We hope to use brain imaging (MRI) to further explore any differences between different people who were previously infected with COVID-19 and those that were not.
Detailed description of study
Participation in this study WILL include one clinic visit lasting approximately 120 minutes in length.
Additionally, you MAY be asked to undergo one research 7T brain MRI scan, lasting approximately 60 minutes in length. This additional scan would be voluntary, and your decision to undergo the MRI would not impact your enrollment in the study.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
COVID-19,HIV
-
Age: Between 18 Years - 65 Years
-
Gender: All
We plan to enroll 90 subjects in this study.
· 30 subjects: HIV+, history of COVID-19 infection > 2 months from study visit
· 30 subjects: HIV+, no history of COVID-19 infection
· 15 subjects: no HIV, history of COVID-19 infection > 2 months from study visit
· 15 subjects: no HIV, no history of COVID-19 infection
Updated on
09 Mar 2024.
Study ID: 850587
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
